GoodRx Holdings, Inc. (GDRX)
Market Cap | 2.80B |
Revenue (ttm) | 750.27M |
Net Income (ttm) | -8.87M |
Shares Out | 395.00M |
EPS (ttm) | -0.02 |
PE Ratio | n/a |
Forward PE | 19.19 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 558,364 |
Open | 6.83 |
Previous Close | 6.96 |
Day's Range | 6.80 - 7.09 |
52-Week Range | 4.14 - 9.37 |
Beta | 1.43 |
Analysts | Buy |
Price Target | 8.94 (+26.27%) |
Earnings Date | May 9, 2024 |
About GDRX
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves ph... [Read more]
Financial Performance
In 2023, GDRX's revenue was $750.27 million, a decrease of -2.12% compared to the previous year's $766.55 million. Losses were -$8.87 million, -72.99% less than in 2022.
Financial StatementsAnalyst Forecast
According to 17 analysts, the average rating for GDRX stock is "Buy." The 12-month stock price forecast is $8.94, which is an increase of 26.27% from the latest price.
News
Contact Levi & Korsinsky by June 21, 2024 Deadline to Join Class Action Against GoodRx Holdings, Inc. (GDRX)
NEW YORK, NY / ACCESSWIRE / April 25, 2024 / If you suffered a loss on your GoodRx Holdings, Inc. (NASDAQ:GDRX) investment and want to learn about a potential recovery under the federal securities law...
IMPORTANT DEADLINE NOTICE: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GoodRx Holdings, Inc. ("GoodRx" ...
GDRX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning GoodRx business and prospects, resulting in its stock trading at inflated prices.
GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK , April 25, 2024 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GoodRx Holdings, I...
GoodRx Announces Date for 2024 Investor Day
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., today announced it will hold its ...
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GoodRx Holdings, Inc. ("GoodRx" ...
GDRX Alert: Rosen, Skilled Investor Counsel, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of GoodRx Holdings, Inc. (NASD...
GDRX INVESTOR ALERT: Kessler Topaz Meltzer & Check, LLP Files A Securities Fraud Class Action Lawsuit Against GoodRX Holdings, Inc. And Encourages Investors With Losses To Contact The Firm
RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against GoodRx Holdings, Inc. (NASDAQ...
GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., today announced it will release i...
GoodRx Adds Publix to GoodRx Gold Network
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx, the leading destination for prescription savings in the U.S., today announced that Publix has joined the GoodRx Gold network. Members now have access to ...
GoodRx Interim CEO Extends Commitment to Company
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., today announced Interim CEO Scott Wagner has extended his com...
GoodRX CEO talks Q4 earnings: Our mission is provide affordable prescription medicine
Shares of GoodRx Holdings (GDRX) are jumping Thursday as the company posted its fourth quarter earnings, revealing revenue increased by 7% to $196.6 million. The company also issued full-year guidance...
GoodRx Reports Fourth Quarter and Full Year 2023 Results
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., has released its financial result...
GoodRx to Participate in Upcoming Investor Conferences
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., today announced that executives f...
GoodRx Now Offering 30 Common Heart Health Medications for Under $30
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx, the leading destination for prescription savings in the U.S., today announced it is offering 30 of the most common heart health medications for under $30...
GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S, today announced it will release it...
GoodRx Leads Provider Ranking of Prescription Apps for Sixth Straight Month
During flu season, you want to be on top of your strategy on how to quickly get better if you're sick. Each month, PYMNTS tracks the most popular mobile apps in the prescription space for the Provider...
GoodRx Announces Proposed Refinancing of First Lien Credit Facilities
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings, today announced its intention to refinance it...
The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), the leading destination for prescription savings, today shared a report looking at the company's impact on social welfare as a result of h...
GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings, today provided preliminary unaudited financia...
GoodRx Appoints Kelly J. Kennedy to Board of Directors
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced the election of Kelly J. Kennedy to its Board of Directors. Ken...
GoodRX Dominates in Latest Provider Ranking of Prescription Apps
Whether you're looking for some relief from a stubborn headache or some vitamins to maintain your wellbeing, a good prescription app will get you what you need. In the latest edition of PYMNTS' Provid...
GoodRx to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced that executives from the Company will participat...
This Analyst With 84% Accuracy Rate Sees Around 22% Upside In NVIDIA - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts - Advance Auto Parts (NYSE:AAP), GoodRx Holdings (NASDAQ:GDRX)
U.S. stocks closed slightly higher on Friday, with the S&P 500 notching gains for the third straight week. The S&P 500 gained 2.2% last week, while the Dow Jones ended the week with a 1.9% gain.
GoodRx to Participate in the Evercore ISI HealthCONx Conference
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced that executives from the Company will participat...